Make your own free website on Tripod.com
Investigation of Bone Augmentation of the Alveolar Ridge Using Implantable Biomaterials

design-page.jpeg

When is bone augmentation needed in the alveolar ridge?

  • atrophy of the edentulous mandible
  • local or extensive bone loss
    • these defects can occur from trauma produced from the removal of teeth, accidents, or disease

Previous technique for augmenting bone:

  • Bone grafting from a donor site in the patient
    • Advantages
      • creates an environment more suitable for osteogenesis
      • biocompatibility with patient not an issue
    • Disadvantages/Clinical Problems:
      • 25% chance of donor site morbidity
      • expensive, increased operative time, extended hospital stay
      • recurrent pain at the harvest site

-Calcium phosphate ceramics are becoming more common to eliminate such clinical problems

  • Purpose: to investigate tissue responses, especially osteogenesis and resorption of Hydroxyapatite(HA) and beta-tri-calcium phosphate(TCP) blocks implanted onto bone.
 
Materials:
  • Hydroxyapatite(HA)
    • used as a bone substitute material because of biocompatibility and nonantigenicity
    • high osteocompatibility and bone binding capacity
    • slow degradation in vivo
    • slow resorption rate when compared to rate of new bone formation
      • can produce an immunological response where HA is attacked as a foreign substance

 

  • Beta-TCP
    • resorbs at a higher rate than HA
      • avoids immunological response
    • highly porous and three-dimensional
      • promotes vascularization
      • structure and porosity resemble human cancellous bone
    • not studied as extensively as HA

btcp.jpg
Figure 1. Optical micrograph of porous beta-TCP.

 

Methods:

  • HA and Beta-TCP blocks with interconnected pores
    • macropore size = 200-400 microns, micropore size = 2 microns
  • 74 six-week-old rats as implant hosts
  • 50% implanted with HA blocks, 50% with Beta-TCP blocks
  • implantation site was between the parietal bone and periosteum
  • rats were killed after 1,2,4,8 and 24 weeks and samples were removed

 

Results:

  • HA had a larger compressive strength over time than Beta-TCP
    • HA = 3.324 MPa, Beta-TCP = 1.732 MPa 
  • amount of newly formed bone was the same for both materials up to 8 weeks
    • new bone growth of HA exceeded that of Beta-TCP after 8 weeks
    • degradation of Beta-TCP occurred after 8 weeks, while HA remained stable
    • fragments engulfed by foreign body giant cells
  • more foreign body giant cells observed on Beta-HCP than HA

 

24.gif
Figure 2. Optical micrograph of bone growth(darker spots) on a hydroxyapatite sample after 24 hours.

Conclusions:

  • HA is more structurally stable that Beta-TCP in vivo and is better for long-term bone tissue growth
  • Beta-TCP cannot be used in any implant site that contains biomechanical stress or micromotion
  • Beta-TCP is more prone to creating an immune response after implantation in the form of foreign body giant cells

Shortcomings/Future Directions:

  • study fails to compare the similarities and differences between implant site and alveolar ridge other than biomechanical response
  • clinical studies should be conducted for several years in order to legitimize HA use in the alveolar ridge
  • Beta-TCP blocks containing osteocytes and growth factors can increase tissue growth
  • divalent ions like Zn and Mg can assist growth factors in being osteoinductive agents
  • heavily cross-linked polymers can be used with Beta-HCP to increase material lifespan in vivo

12-alpha.jpg
Hydroxyapatite blocks before implantation(courtesy of Berkeley Advanced Biomaterials, Inc.)

Resources:
 

Reference Manuscripts and Other Articles of Interest:
 
  1. A Gaggl, G Schultes, H Karchner. Distraction implants: a new operative technique for alveolar ridge reconstruction. Journal of Craniofacial Surgery 4 (1999), pp. 214-221.
  2. Orthovida Biological Products. http://www.orthovita.com/products/vitoss/tcp/us.html (2003).
  3. I.T. Jackson, G. Helden and R. Marx, Skull bone grafts in maxillofacial and craniofacial surgery. J Oral Maxillofac Surg 44 (1986), p. 949.
  4. S.A. Wolfe, Autogenous bone grafts versus alloplastic material in maxillofacial surgery. Clin Plast Surg 9 (1982), p. 539.
  5. J.L. Ricci, N.C. Blummenthal, J.M. Spivak et al., Evaluation of a low temperature calcium phosphate particulate implant material: Physical chemical properties and in vivo bone response. J Oral Maxillofac Surg 50 (1992), p. 969.
  6. L.L. Hench and E.C. Ethridge, Biomaterials, an interfacial approach. In: A. Noordergraaf, Editor, Biophysics and Bioengineering Series, Academic Press, New York, NY (1982), pp. 126148.
  7. C.P.A.T. Klein, A.A. Driessen, K. de Groot et al., Biodegradation behavior of various calcium phosphate materials in bone tissue. J Biomed Mater Res 17 (1983), p. 769.
  8. H.A. Hoogendoorn, W. Renooij and L.M.A. Akkermans, Long-term study of large ceramic implants (porous hydroxyapatite) in dog femora. Clin Orthop 187 (1984), p. 281.
  9. R. Fujita, A Yokohama, T. Kawasaki, T Kohgo. Bone augmentation osteogenesis using hydroxyapatite and b-tricalcium  phosphate blocks. Journal of Oral and Maxillofacial Surgery. 61 (2003). pp 1045-1053.
 

Website created by:
Ashley A. John
Department of Materials Science and Engineering
University of Illinois at Urbana-Champaign
Fall 2003

powered by lycos
SEARCH:Tripod The Web